Lab Anim Res.  2024 Sep;40(3):292-306. 10.1186/s42826-024-00218-2.

Flavonoids as therapeutics for myocardial ischemia-reperfusion injury: a comprehensive review on preclinical studies

• Verma VK
• Bhardwaj P
• Prajapati V
• Bhatia A
• Purkait S
• Arya DS

• KMID: 2560010
• DOI: http://doi.org/10.1186/s42826-024-00218-2

Abstract

Ischemic heart disease is the most prevalent cause of death worldwide affecting both the gender of all age groups. The high mortality rate is due to damage of myocardial tissue that emanates at the time of myocardial ischemia and re-oxygenation, thus averting reperfusion injury is recognized as a potential way to reduce acute cardiac injury and subsequent mortality. Flavonoids are polyphenol derivatives of plant origin and empirical shreds of evidence substantiate their numerous activities such as antioxidant, anti-inflammatory, anti-apoptotic, and anti-thrombotic activity, leading to their role in cardio protection. Recent investigations have unveiled the capacity of flavonoids to impede pivotal regulatory enzymes, signaling molecules, and transcription factors that orchestrate the mediators participating in the inflammatory cascade. The present comprehensive review, dwells on the preclinical studies on the effectiveness of flavonoids from the year 2007 to 2023, for the prevention and therapeutics for myocardial ischemia-reperfusion injury.

Keyword

Inflammation; Flavonoids; Myocardial ischemia-reperfusion injury; Preclinical studies; Reactive oxygen species; Re-oxygenation